Summary

Nucleic Acid Labeling Market
The nucleic acid labeling market was valued at $2.5 billion in 2023 and is projected to reach $5.1 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
Nucleic acid labeling is a biomolecular technique that involves the attachment of a detectable marker to nucleic acids, both DNA and RNA. This technique enables the tracking, analysis, or study of the presence, distribution, quantity, or sequence of nucleic acid. It finds applications in gene expression analysis, in-situ hybridization, PCR assays, and single-molecule analysis.

Rise in focus on genomic research and surge in the popularity of precision medicine are the key drivers of the nucleic acid labeling market. In addition, the technique plays a crucial role in facilitating early disease detection and proactive treatments, which augments the market growth significantly. Furthermore, expansion of the point-of-care testing approach is fueling the requirement for nucleic acid labeling infrastructure and propelling the development of the market. To enhance the precision and effectiveness of labeling, the development of next-generation fluorescent probes and nanoparticle-based labels is becoming a prominent trend in the market. These labels exhibit high sensitivity, which is essential to improve the signal-to-noise ratio of the process.
However, the high cost of reagents & equipment required to accomplish nucleic acid labeling deters several small-scale laboratories and institutions from their procurement, which hampers the growth of the market. Moreover, increase in the shortage of skilled workforce to conduct the labeling technique limits its adoption and restrains the nucleic acid labeling market. Contrarily, rise in expenditure and investments in the biopharmaceutical industry is poised to present lucrative opportunities for the nucleic acid labeling market. The technique is essential for the industry to discover, validate, and monitor the drugs, biomarkers, and therapeutic responses. According to IQVIA—an American professional consulting and biopharmaceutical development provider—the global funding for biopharmaceutical R&D upsurged from $61 billion in 2022 to $72 billion in 2023. Therefore, the nucleic acid labeling market is poised to witness several new avenues with increasing investments.

Segment Review
The nucleic acid labeling market is segmented into product, labeling techniques, application, and region. On the basis of product, the market is bifurcated into kits & reagents and services. Depending on labeling techniques, it is divided into PCR, nick translation, random primer, in-vitro transcription, reverse transcription, and end labelling. As per application, it is classified into DNA sequencing, PCR, FISH, microarray, in-situ hybridization, blotting, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product, the kits & reagents & reagents segment held a high share of the market in 2023.
Depending on labeling techniques, the PCR segment dominated the market in 2023.
As per application, the FISH segment was the highest shareholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players in the global nucleic acid labeling market include Merck & Co., Inc., PerkinElmer, Inc., New England Biolabs, Inc., F. Hoffmann La-Roche AG, Enzo Biochem Inc., GE Healthcare, Vector Laboratories, Inc., Promega Corporation, Agilent Technologies, and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● New Product Development/ Product Matrix of Key Players
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Expanded list for Company Profiles
● Historic market data
Key Market Segments
By Product
● Kits and Reagents
● Services
By Labeling Techniques
● PCR
● Nick Translation
● Random Primer
● In Vitro Transcription
● Reverse Transcription
● End Labelling
By Application
● DNA Sequencing
● PCR
● FISH
● Microarray
● In Situ Hybridization
● Blotting
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ Australia
○ India
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● Key Market Players
○ Merck & Co., Inc.
○ PerkinElmer, Inc
○ New England Biolabs, Inc.
○ F. Hoffmann La-Roche AG
○ Enzo Biochem Inc.
○ GE Healthcare
○ vector laboratories, inc.
○ Promega Corporation
○ Agilent Technologies
○ Thermo Fisher Scientific

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: NUCLEIC ACID LABELING MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Kits And Reagents
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Services
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: NUCLEIC ACID LABELING MARKET, BY LABELING TECHNIQUES
5.1. Market Overview
5.1.1 Market Size and Forecast, By Labeling Techniques
5.2. PCR
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Nick Translation
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Random Primer
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. In Vitro Transcription
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Reverse Transcription
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
5.7. End Labelling
5.7.1. Key Market Trends, Growth Factors and Opportunities
5.7.2. Market Size and Forecast, By Region
5.7.3. Market Share Analysis, By Country
CHAPTER 6: NUCLEIC ACID LABELING MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. DNA Sequencing
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. PCR
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. FISH
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Microarray
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. In Situ Hybridization
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
6.7. Blotting
6.7.1. Key Market Trends, Growth Factors and Opportunities
6.7.2. Market Size and Forecast, By Region
6.7.3. Market Share Analysis, By Country
6.8. Others
6.8.1. Key Market Trends, Growth Factors and Opportunities
6.8.2. Market Size and Forecast, By Region
6.8.3. Market Share Analysis, By Country
CHAPTER 7: NUCLEIC ACID LABELING MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Product
7.2.3. Market Size and Forecast, By Labeling Techniques
7.2.4. Market Size and Forecast, By Application
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Nucleic Acid Labeling Market
7.2.6.1. Market Size and Forecast, By Product
7.2.6.2. Market Size and Forecast, By Labeling Techniques
7.2.6.3. Market Size and Forecast, By Application
7.2.7. Canada Nucleic Acid Labeling Market
7.2.7.1. Market Size and Forecast, By Product
7.2.7.2. Market Size and Forecast, By Labeling Techniques
7.2.7.3. Market Size and Forecast, By Application
7.2.8. Mexico Nucleic Acid Labeling Market
7.2.8.1. Market Size and Forecast, By Product
7.2.8.2. Market Size and Forecast, By Labeling Techniques
7.2.8.3. Market Size and Forecast, By Application
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Product
7.3.3. Market Size and Forecast, By Labeling Techniques
7.3.4. Market Size and Forecast, By Application
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Nucleic Acid Labeling Market
7.3.6.1. Market Size and Forecast, By Product
7.3.6.2. Market Size and Forecast, By Labeling Techniques
7.3.6.3. Market Size and Forecast, By Application
7.3.7. France Nucleic Acid Labeling Market
7.3.7.1. Market Size and Forecast, By Product
7.3.7.2. Market Size and Forecast, By Labeling Techniques
7.3.7.3. Market Size and Forecast, By Application
7.3.8. UK Nucleic Acid Labeling Market
7.3.8.1. Market Size and Forecast, By Product
7.3.8.2. Market Size and Forecast, By Labeling Techniques
7.3.8.3. Market Size and Forecast, By Application
7.3.9. Italy Nucleic Acid Labeling Market
7.3.9.1. Market Size and Forecast, By Product
7.3.9.2. Market Size and Forecast, By Labeling Techniques
7.3.9.3. Market Size and Forecast, By Application
7.3.10. Spain Nucleic Acid Labeling Market
7.3.10.1. Market Size and Forecast, By Product
7.3.10.2. Market Size and Forecast, By Labeling Techniques
7.3.10.3. Market Size and Forecast, By Application
7.3.11. Rest Of Europe Nucleic Acid Labeling Market
7.3.11.1. Market Size and Forecast, By Product
7.3.11.2. Market Size and Forecast, By Labeling Techniques
7.3.11.3. Market Size and Forecast, By Application
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Product
7.4.3. Market Size and Forecast, By Labeling Techniques
7.4.4. Market Size and Forecast, By Application
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Nucleic Acid Labeling Market
7.4.6.1. Market Size and Forecast, By Product
7.4.6.2. Market Size and Forecast, By Labeling Techniques
7.4.6.3. Market Size and Forecast, By Application
7.4.7. China Nucleic Acid Labeling Market
7.4.7.1. Market Size and Forecast, By Product
7.4.7.2. Market Size and Forecast, By Labeling Techniques
7.4.7.3. Market Size and Forecast, By Application
7.4.8. Australia Nucleic Acid Labeling Market
7.4.8.1. Market Size and Forecast, By Product
7.4.8.2. Market Size and Forecast, By Labeling Techniques
7.4.8.3. Market Size and Forecast, By Application
7.4.9. India Nucleic Acid Labeling Market
7.4.9.1. Market Size and Forecast, By Product
7.4.9.2. Market Size and Forecast, By Labeling Techniques
7.4.9.3. Market Size and Forecast, By Application
7.4.10. South Korea Nucleic Acid Labeling Market
7.4.10.1. Market Size and Forecast, By Product
7.4.10.2. Market Size and Forecast, By Labeling Techniques
7.4.10.3. Market Size and Forecast, By Application
7.4.11. Rest of Asia-Pacific Nucleic Acid Labeling Market
7.4.11.1. Market Size and Forecast, By Product
7.4.11.2. Market Size and Forecast, By Labeling Techniques
7.4.11.3. Market Size and Forecast, By Application
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Product
7.5.3. Market Size and Forecast, By Labeling Techniques
7.5.4. Market Size and Forecast, By Application
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Nucleic Acid Labeling Market
7.5.6.1. Market Size and Forecast, By Product
7.5.6.2. Market Size and Forecast, By Labeling Techniques
7.5.6.3. Market Size and Forecast, By Application
7.5.7. Saudi Arabia Nucleic Acid Labeling Market
7.5.7.1. Market Size and Forecast, By Product
7.5.7.2. Market Size and Forecast, By Labeling Techniques
7.5.7.3. Market Size and Forecast, By Application
7.5.8. South Africa Nucleic Acid Labeling Market
7.5.8.1. Market Size and Forecast, By Product
7.5.8.2. Market Size and Forecast, By Labeling Techniques
7.5.8.3. Market Size and Forecast, By Application
7.5.9. Rest of LAMEA Nucleic Acid Labeling Market
7.5.9.1. Market Size and Forecast, By Product
7.5.9.2. Market Size and Forecast, By Labeling Techniques
7.5.9.3. Market Size and Forecast, By Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Merck And Co., Inc.
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. PerkinElmer, Inc
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. New England Biolabs, Inc.
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. F. Hoffmann La-Roche AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Enzo Biochem Inc.
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. GE Healthcare
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. Vector Laboratories, Inc.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Promega Corporation
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Agilent Technologies
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Thermo Fisher Scientific
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments